Rank | Gene Set | Z-score |
---|---|---|
1 | protein heterotrimerization (GO:0070208) | 5.46598663 |
2 | carnitine shuttle (GO:0006853) | 4.88884113 |
3 | fatty acid transmembrane transport (GO:1902001) | 4.72727578 |
4 | cardiac myofibril assembly (GO:0055003) | 4.52959767 |
5 | sarcomere organization (GO:0045214) | 4.47412088 |
6 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.46990583 |
7 | regulation of sequestering of triglyceride (GO:0010889) | 4.43263380 |
8 | plasma membrane repair (GO:0001778) | 4.39169722 |
9 | actin-myosin filament sliding (GO:0033275) | 4.28700616 |
10 | muscle filament sliding (GO:0030049) | 4.28700616 |
11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.25174579 |
12 | positive regulation of fatty acid oxidation (GO:0046321) | 4.08987317 |
13 | myofibril assembly (GO:0030239) | 4.08560124 |
14 | low-density lipoprotein particle clearance (GO:0034383) | 4.04156609 |
15 | regulation of skeletal muscle contraction (GO:0014819) | 4.02472001 |
16 | carnitine transmembrane transport (GO:1902603) | 3.74409954 |
17 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.72193822 |
18 | regulation of fatty acid oxidation (GO:0046320) | 3.71584039 |
19 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.67655410 |
20 | actin-mediated cell contraction (GO:0070252) | 3.67329298 |
21 | hemidesmosome assembly (GO:0031581) | 3.65483161 |
22 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.62656580 |
23 | cell migration involved in heart development (GO:0060973) | 3.60149279 |
24 | cellular response to epinephrine stimulus (GO:0071872) | 3.57184741 |
25 | * collagen fibril organization (GO:0030199) | 3.53258536 |
26 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 3.51813715 |
27 | negative regulation of heart growth (GO:0061117) | 3.51813715 |
28 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.46891289 |
29 | collagen catabolic process (GO:0030574) | 3.46238879 |
30 | lipid particle organization (GO:0034389) | 3.45181395 |
31 | carnitine transport (GO:0015879) | 3.42598152 |
32 | amino-acid betaine transport (GO:0015838) | 3.42598152 |
33 | barbed-end actin filament capping (GO:0051016) | 3.39823301 |
34 | biotin metabolic process (GO:0006768) | 3.37071299 |
35 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.35962237 |
36 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.34736420 |
37 | * collagen metabolic process (GO:0032963) | 3.32812510 |
38 | regulation of p38MAPK cascade (GO:1900744) | 3.30746684 |
39 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 3.28656836 |
40 | tricarboxylic acid cycle (GO:0006099) | 3.27465598 |
41 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.26637909 |
42 | multicellular organismal catabolic process (GO:0044243) | 3.26549031 |
43 | * extracellular matrix assembly (GO:0085029) | 3.24428799 |
44 | skeletal muscle adaptation (GO:0043501) | 3.23281340 |
45 | heart trabecula formation (GO:0060347) | 3.17855387 |
46 | * multicellular organismal metabolic process (GO:0044236) | 3.15831223 |
47 | brown fat cell differentiation (GO:0050873) | 3.15400335 |
48 | fatty acid beta-oxidation (GO:0006635) | 3.14903422 |
49 | cardiac muscle cell development (GO:0055013) | 3.13011163 |
50 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.12809787 |
51 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.11733144 |
52 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.10107802 |
53 | cardiac muscle contraction (GO:0060048) | 3.10042359 |
54 | actomyosin structure organization (GO:0031032) | 3.06724485 |
55 | striated muscle hypertrophy (GO:0014897) | 3.05880613 |
56 | valine metabolic process (GO:0006573) | 3.04533539 |
57 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.03469176 |
58 | desmosome organization (GO:0002934) | 3.03226654 |
59 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.03220586 |
60 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.02735165 |
61 | actin filament-based movement (GO:0030048) | 3.02176537 |
62 | cardiac cell development (GO:0055006) | 3.00930249 |
63 | triglyceride catabolic process (GO:0019433) | 3.00533148 |
64 | response to epinephrine (GO:0071871) | 2.99499836 |
65 | myelination in peripheral nervous system (GO:0022011) | 2.97589928 |
66 | peripheral nervous system axon ensheathment (GO:0032292) | 2.97589928 |
67 | endocrine hormone secretion (GO:0060986) | 2.96227142 |
68 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.93978353 |
69 | extracellular matrix disassembly (GO:0022617) | 2.90733155 |
70 | trabecula formation (GO:0060343) | 2.89142243 |
71 | creatine metabolic process (GO:0006600) | 2.88987262 |
72 | cell-substrate junction assembly (GO:0007044) | 2.88351684 |
73 | 2-oxoglutarate metabolic process (GO:0006103) | 2.87629509 |
74 | glomerular filtration (GO:0003094) | 2.87241695 |
75 | regulation of relaxation of muscle (GO:1901077) | 2.85599045 |
76 | basement membrane organization (GO:0071711) | 2.85521309 |
77 | intracellular lipid transport (GO:0032365) | 2.83524308 |
78 | fibroblast migration (GO:0010761) | 2.82832038 |
79 | apoptotic cell clearance (GO:0043277) | 2.82743669 |
80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.82416393 |
81 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.82409265 |
82 | white fat cell differentiation (GO:0050872) | 2.82389258 |
83 | keratan sulfate catabolic process (GO:0042340) | 2.80560672 |
84 | glomerular basement membrane development (GO:0032836) | 2.80397173 |
85 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.79799938 |
86 | epithelial cell-cell adhesion (GO:0090136) | 2.79723830 |
87 | surfactant homeostasis (GO:0043129) | 2.79409297 |
88 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.77595138 |
89 | growth hormone secretion (GO:0030252) | 2.76866462 |
90 | ovulation from ovarian follicle (GO:0001542) | 2.76720579 |
91 | atrioventricular valve morphogenesis (GO:0003181) | 2.73600108 |
92 | positive regulation of p38MAPK cascade (GO:1900745) | 2.73440164 |
93 | renal filtration (GO:0097205) | 2.72295776 |
94 | regulation of cholesterol storage (GO:0010885) | 2.72251521 |
95 | positive regulation of receptor recycling (GO:0001921) | 2.72066730 |
96 | cGMP-mediated signaling (GO:0019934) | 2.71776154 |
97 | muscle hypertrophy (GO:0014896) | 2.71671170 |
98 | neutral lipid catabolic process (GO:0046461) | 2.71190616 |
99 | acylglycerol catabolic process (GO:0046464) | 2.71190616 |
100 | bone trabecula formation (GO:0060346) | 2.69705316 |
101 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.68778297 |
102 | regulation of actin filament-based movement (GO:1903115) | 2.68538398 |
103 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.68061571 |
104 | blood vessel maturation (GO:0001955) | 2.67592529 |
105 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.67390147 |
106 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.66925427 |
107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.66577397 |
108 | metanephric mesenchyme development (GO:0072075) | 2.66531407 |
109 | fatty acid oxidation (GO:0019395) | 2.65306908 |
110 | metanephric nephron epithelium development (GO:0072243) | 2.65133887 |
111 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.65054573 |
112 | cell proliferation involved in metanephros development (GO:0072203) | 2.64951724 |
113 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.64331820 |
114 | NADH metabolic process (GO:0006734) | 2.64235011 |
115 | * extracellular fibril organization (GO:0043206) | 2.64141718 |
116 | positive regulation of glycogen metabolic process (GO:0070875) | 2.63828930 |
117 | negative regulation of fatty acid transport (GO:2000192) | 2.62518310 |
118 | skin morphogenesis (GO:0043589) | 2.62315481 |
119 | negative regulation of muscle hypertrophy (GO:0014741) | 2.62046732 |
120 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.61284202 |
121 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.59918586 |
122 | fatty acid catabolic process (GO:0009062) | 2.59543046 |
123 | negative regulation of stress fiber assembly (GO:0051497) | 2.59346135 |
124 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.57882795 |
125 | endothelium development (GO:0003158) | 2.54231424 |
126 | endothelial cell morphogenesis (GO:0001886) | 2.53037297 |
127 | negative regulation of protein localization to cell surface (GO:2000009) | 2.52373629 |
128 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.51974516 |
129 | cell volume homeostasis (GO:0006884) | 2.51853733 |
130 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50903493 |
131 | cardiac muscle hypertrophy (GO:0003300) | 2.50362356 |
132 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.49705390 |
133 | metanephric tubule development (GO:0072170) | 2.49505232 |
134 | metanephric nephron tubule development (GO:0072234) | 2.49505232 |
135 | adherens junction assembly (GO:0034333) | 2.43848106 |
136 | metanephric epithelium development (GO:0072207) | 2.43498306 |
137 | positive regulation of cholesterol efflux (GO:0010875) | 2.42409240 |
138 | response to water (GO:0009415) | 2.42231238 |
139 | positive regulation of protein kinase C signaling (GO:0090037) | 2.40876257 |
140 | stress fiber assembly (GO:0043149) | 2.39718392 |
141 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.39580643 |
142 | lymphangiogenesis (GO:0001946) | 2.38566232 |
143 | * fibril organization (GO:0097435) | 2.38385962 |
144 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.37138210 |
145 | focal adhesion assembly (GO:0048041) | 2.34406234 |
146 | cell-substrate adherens junction assembly (GO:0007045) | 2.34406234 |
147 | phagocytosis, recognition (GO:0006910) | 2.34139382 |
148 | cellular response to monoamine stimulus (GO:0071868) | 2.34033521 |
149 | cellular response to catecholamine stimulus (GO:0071870) | 2.34033521 |
150 | angiogenesis involved in wound healing (GO:0060055) | 2.33388487 |
151 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.32126088 |
152 | endothelial cell chemotaxis (GO:0035767) | 2.30347723 |
153 | adhesion of symbiont to host cell (GO:0044650) | 2.29893784 |
154 | virion attachment to host cell (GO:0019062) | 2.29893784 |
155 | protein localization to cell surface (GO:0034394) | 2.29317247 |
156 | cellular response to growth hormone stimulus (GO:0071378) | 2.29255138 |
157 | smooth muscle tissue development (GO:0048745) | 2.29119244 |
158 | kidney mesenchyme development (GO:0072074) | 2.28982203 |
159 | polyol transport (GO:0015791) | 2.28334866 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.53300471 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.31974037 |
3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.75542525 |
4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.25031199 |
5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.02877689 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87916449 |
7 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.45399542 |
8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.34887346 |
9 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.30599377 |
10 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.30267968 |
11 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.19023301 |
12 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.14095012 |
13 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.14095012 |
14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11214280 |
15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04799854 |
16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99213917 |
17 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.93264508 |
18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.92721174 |
19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.88019151 |
20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.81182676 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.80435300 |
22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74592412 |
23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.71454828 |
24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.70722145 |
25 | CJUN_26792858_Chip-Seq_BT549_Human | 1.64279719 |
26 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.61894251 |
27 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.61813925 |
28 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61765886 |
29 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.55319032 |
30 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53498550 |
31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50395989 |
32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.46524881 |
33 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45502499 |
34 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41461818 |
35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.41374280 |
36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.41132871 |
37 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40186303 |
38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.39146716 |
39 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38780801 |
40 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38203143 |
41 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35351144 |
42 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34460308 |
43 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33865050 |
44 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32842938 |
45 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.30090916 |
46 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.26352936 |
47 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.25398791 |
48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25276598 |
49 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22524060 |
50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21010470 |
51 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.20301767 |
52 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20013164 |
53 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20013164 |
54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19332703 |
55 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.18923648 |
56 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.18918505 |
57 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18318174 |
58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15980209 |
59 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.15241685 |
60 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.13466564 |
61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13464095 |
62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13291590 |
63 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12573574 |
64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11003594 |
65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.10496638 |
66 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.10242833 |
67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08172530 |
68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.05796894 |
69 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.04850181 |
70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.04607392 |
71 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.04537408 |
72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03957417 |
73 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03064087 |
74 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02885596 |
75 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01999383 |
76 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.01182747 |
77 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00780115 |
78 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00336922 |
79 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99871888 |
80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.99704264 |
81 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.99668233 |
82 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.99339370 |
83 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98391702 |
84 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98263478 |
85 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.97941313 |
86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97390507 |
87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97275356 |
88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96043171 |
89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95456496 |
90 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.95234524 |
91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.94496124 |
92 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.94496124 |
93 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94144720 |
94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93514093 |
95 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93480939 |
96 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.92812160 |
97 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.92044586 |
98 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91989492 |
99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91061527 |
100 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.90969840 |
101 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.90880816 |
102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90457016 |
103 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.89872711 |
104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.89551943 |
105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.89551943 |
106 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.88363520 |
107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88077624 |
108 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.88030177 |
109 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.86891226 |
110 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86822040 |
111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.86329864 |
112 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86217597 |
113 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86069681 |
114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.85680516 |
115 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.85156807 |
116 | ATF3_27146783_Chip-Seq_COLON_Human | 0.84319319 |
117 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.83772746 |
118 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83346401 |
119 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83024993 |
120 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.82734303 |
121 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82599109 |
122 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.82028253 |
123 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81965482 |
124 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81640426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0008438_abnormal_cutaneous_collagen | 5.46283464 |
2 | * MP0005275_abnormal_skin_tensile | 4.85191635 |
3 | MP0002837_dystrophic_cardiac_calcinosis | 4.60235540 |
4 | MP0000751_myopathy | 4.36687984 |
5 | MP0005503_abnormal_tendon_morphology | 3.42863204 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.38223498 |
7 | MP0005670_abnormal_white_adipose | 3.36734262 |
8 | MP0004084_abnormal_cardiac_muscle | 2.89223455 |
9 | MP0004130_abnormal_muscle_cell | 2.86827377 |
10 | MP0004272_abnormal_basement_membrane | 2.63833066 |
11 | MP0003646_muscle_fatigue | 2.56984420 |
12 | MP0005666_abnormal_adipose_tissue | 2.56909456 |
13 | MP0001958_emphysema | 2.55962609 |
14 | MP0000749_muscle_degeneration | 2.43039596 |
15 | MP0004036_abnormal_muscle_relaxation | 2.41792336 |
16 | MP0000750_abnormal_muscle_regeneration | 2.39805715 |
17 | MP0005330_cardiomyopathy | 2.37072622 |
18 | MP0004215_abnormal_myocardial_fiber | 2.32145497 |
19 | MP0004185_abnormal_adipocyte_glucose | 2.19868218 |
20 | MP0004087_abnormal_muscle_fiber | 2.15366664 |
21 | MP0003279_aneurysm | 2.02108600 |
22 | MP0005375_adipose_tissue_phenotype | 2.00408827 |
23 | MP0002108_abnormal_muscle_morphology | 1.98729517 |
24 | MP0005620_abnormal_muscle_contractility | 1.80097118 |
25 | MP0000013_abnormal_adipose_tissue | 1.77742609 |
26 | MP0002106_abnormal_muscle_physiology | 1.77156037 |
27 | * MP0002060_abnormal_skin_morphology | 1.76477451 |
28 | MP0004145_abnormal_muscle_electrophysio | 1.70649306 |
29 | MP0001544_abnormal_cardiovascular_syste | 1.68272536 |
30 | MP0005385_cardiovascular_system_phenoty | 1.68272536 |
31 | MP0006138_congestive_heart_failure | 1.67817762 |
32 | MP0002972_abnormal_cardiac_muscle | 1.65503596 |
33 | MP0008775_abnormal_heart_ventricle | 1.65290817 |
34 | MP0003566_abnormal_cell_adhesion | 1.64057292 |
35 | MP0005369_muscle_phenotype | 1.62328314 |
36 | MP0000759_abnormal_skeletal_muscle | 1.61444949 |
37 | MP0010368_abnormal_lymphatic_system | 1.55688755 |
38 | MP0010630_abnormal_cardiac_muscle | 1.53859814 |
39 | MP0000747_muscle_weakness | 1.52244784 |
40 | MP0002933_joint_inflammation | 1.47611289 |
41 | MP0000003_abnormal_adipose_tissue | 1.46373995 |
42 | MP0003828_pulmonary_edema | 1.45281915 |
43 | MP0005409_darkened_coat_color | 1.41262590 |
44 | MP0002269_muscular_atrophy | 1.38144680 |
45 | MP0003045_fibrosis | 1.35340028 |
46 | MP0005257_abnormal_intraocular_pressure | 1.31643266 |
47 | MP0004484_altered_response_of | 1.28578450 |
48 | MP0002971_abnormal_brown_adipose | 1.28110753 |
49 | MP0002796_impaired_skin_barrier | 1.26126780 |
50 | MP0001542_abnormal_bone_strength | 1.25117432 |
51 | MP0004858_abnormal_nervous_system | 1.20325431 |
52 | MP0003191_abnormal_cellular_cholesterol | 1.17417738 |
53 | MP0000343_altered_response_to | 1.16220006 |
54 | MP0003950_abnormal_plasma_membrane | 1.14634837 |
55 | MP0001879_abnormal_lymphatic_vessel | 1.09554761 |
56 | MP0003137_abnormal_impulse_conducting | 1.09405415 |
57 | MP0005171_absent_coat_pigmentation | 1.08249275 |
58 | MP0009115_abnormal_fat_cell | 1.07985256 |
59 | MP0006054_spinal_hemorrhage | 1.07487658 |
60 | MP0002295_abnormal_pulmonary_circulatio | 1.05078685 |
61 | MP0000579_abnormal_nail_morphology | 1.02634375 |
62 | MP0000733_abnormal_muscle_development | 0.99923158 |
63 | MP0002254_reproductive_system_inflammat | 0.97677606 |
64 | MP0001243_abnormal_dermal_layer | 0.95273779 |
65 | MP0005508_abnormal_skeleton_morphology | 0.93855499 |
66 | MP0002249_abnormal_larynx_morphology | 0.93770392 |
67 | MP0005623_abnormal_meninges_morphology | 0.92216309 |
68 | MP0001661_extended_life_span | 0.92033703 |
69 | MP0005334_abnormal_fat_pad | 0.91743747 |
70 | MP0004085_abnormal_heartbeat | 0.90969498 |
71 | MP0010329_abnormal_lipoprotein_level | 0.89889107 |
72 | MP0002998_abnormal_bone_remodeling | 0.89815191 |
73 | MP0005164_abnormal_response_to | 0.88424557 |
74 | MP0000767_abnormal_smooth_muscle | 0.87805879 |
75 | MP0004510_myositis | 0.87208176 |
76 | MP0009384_cardiac_valve_regurgitation | 0.85033950 |
77 | MP0009780_abnormal_chondrocyte_physiolo | 0.81439137 |
78 | MP0008004_abnormal_stomach_pH | 0.78462126 |
79 | MP0002128_abnormal_blood_circulation | 0.77317839 |
80 | MP0005390_skeleton_phenotype | 0.76766298 |
81 | MP0001299_abnormal_eye_distance/ | 0.76161427 |
82 | MP0000163_abnormal_cartilage_morphology | 0.75385080 |
83 | MP0002168_other_aberrant_phenotype | 0.74908855 |
84 | MP0000266_abnormal_heart_morphology | 0.74652529 |
85 | MP0004233_abnormal_muscle_weight | 0.74589321 |
86 | MP0002332_abnormal_exercise_endurance | 0.73603908 |
87 | MP0002970_abnormal_white_adipose | 0.72972454 |
88 | MP0005165_increased_susceptibility_to | 0.72887586 |
89 | MP0002118_abnormal_lipid_homeostasis | 0.72786620 |
90 | MP0005595_abnormal_vascular_smooth | 0.69515072 |
91 | MP0003879_abnormal_hair_cell | 0.69441629 |
92 | MP0000230_abnormal_systemic_arterial | 0.69147306 |
93 | MP0002133_abnormal_respiratory_system | 0.68536858 |
94 | MP0005388_respiratory_system_phenotype | 0.68536858 |
95 | MP0002896_abnormal_bone_mineralization | 0.66143797 |
96 | MP0004782_abnormal_surfactant_physiolog | 0.65909352 |
97 | MP0005023_abnormal_wound_healing | 0.65653676 |
98 | MP0002234_abnormal_pharynx_morphology | 0.64264646 |
99 | MP0008961_abnormal_basal_metabolism | 0.63822766 |
100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.62587976 |
101 | MP0002115_abnormal_skeleton_extremities | 0.62519298 |
102 | MP0003959_abnormal_lean_body | 0.62335470 |
103 | MP0001849_ear_inflammation | 0.61347934 |
104 | MP0002127_abnormal_cardiovascular_syste | 0.58397362 |
105 | MP0005501_abnormal_skin_physiology | 0.57383698 |
106 | MP0001756_abnormal_urination | 0.57093160 |
107 | MP0001614_abnormal_blood_vessel | 0.56265397 |
108 | MP0003724_increased_susceptibility_to | 0.56242679 |
109 | * MP0010771_integument_phenotype | 0.54471588 |
110 | MP0005076_abnormal_cell_differentiation | 0.54353268 |
111 | MP0005167_abnormal_blood-brain_barrier | 0.53964394 |
112 | MP0003252_abnormal_bile_duct | 0.53232903 |
113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.53057114 |
114 | MP0003091_abnormal_cell_migration | 0.50886438 |
115 | MP0000467_abnormal_esophagus_morphology | 0.49203058 |
116 | MP0000249_abnormal_blood_vessel | 0.47754772 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.47054993 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Type 1 muscle fiber predominance (HP:0003803) | 6.30525353 |
2 | Ankle contracture (HP:0006466) | 5.53734930 |
3 | * Increased connective tissue (HP:0009025) | 4.96557234 |
4 | Broad metatarsal (HP:0001783) | 4.93491532 |
5 | Protrusio acetabuli (HP:0003179) | 4.79276191 |
6 | Increased variability in muscle fiber diameter (HP:0003557) | 4.55648099 |
7 | Sudden death (HP:0001699) | 4.54750103 |
8 | Follicular hyperkeratosis (HP:0007502) | 4.47903287 |
9 | Premature rupture of membranes (HP:0001788) | 4.43821458 |
10 | Right ventricular cardiomyopathy (HP:0011663) | 4.18500621 |
11 | Slender build (HP:0001533) | 4.15026908 |
12 | Hyporeflexia of lower limbs (HP:0002600) | 4.13290346 |
13 | Spinal rigidity (HP:0003306) | 4.11345057 |
14 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.09588583 |
15 | Aortic dissection (HP:0002647) | 4.04397122 |
16 | Mildly elevated creatine phosphokinase (HP:0008180) | 4.02575547 |
17 | Cerebral aneurysm (HP:0004944) | 3.99619064 |
18 | Ventricular tachycardia (HP:0004756) | 3.99006217 |
19 | Exercise-induced myalgia (HP:0003738) | 3.78295241 |
20 | * Muscle fiber splitting (HP:0003555) | 3.73483007 |
21 | Calf muscle hypertrophy (HP:0008981) | 3.70071795 |
22 | Lipoatrophy (HP:0100578) | 3.66769608 |
23 | Atrophic scars (HP:0001075) | 3.50349602 |
24 | Fragile skin (HP:0001030) | 3.47046369 |
25 | Difficulty running (HP:0009046) | 3.45716494 |
26 | Abnormality of the calf musculature (HP:0001430) | 3.40622710 |
27 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.35852228 |
28 | Exercise-induced muscle cramps (HP:0003710) | 3.24635160 |
29 | Myoglobinuria (HP:0002913) | 3.20707894 |
30 | Aortic aneurysm (HP:0004942) | 3.18689957 |
31 | Round ear (HP:0100830) | 3.14160074 |
32 | Vascular tortuosity (HP:0004948) | 3.14038360 |
33 | Obstructive sleep apnea (HP:0002870) | 3.08226106 |
34 | Shallow orbits (HP:0000586) | 3.02915898 |
35 | Ulnar deviation of the wrist (HP:0003049) | 3.02505028 |
36 | Atrial fibrillation (HP:0005110) | 2.97494180 |
37 | Cervical subluxation (HP:0003308) | 2.95352347 |
38 | Bladder diverticulum (HP:0000015) | 2.93031718 |
39 | Abnormality of complement system (HP:0005339) | 2.81575756 |
40 | Primary atrial arrhythmia (HP:0001692) | 2.72972225 |
41 | EMG: myopathic abnormalities (HP:0003458) | 2.71934225 |
42 | Myotonia (HP:0002486) | 2.71843356 |
43 | Supraventricular arrhythmia (HP:0005115) | 2.65002112 |
44 | Wrist flexion contracture (HP:0001239) | 2.61583191 |
45 | Supraventricular tachycardia (HP:0004755) | 2.58622397 |
46 | Arterial tortuosity (HP:0005116) | 2.55145466 |
47 | Rectal prolapse (HP:0002035) | 2.49159802 |
48 | Polycythemia (HP:0001901) | 2.49015276 |
49 | Dilated cardiomyopathy (HP:0001644) | 2.48078915 |
50 | Difficulty climbing stairs (HP:0003551) | 2.47755618 |
51 | Aortic regurgitation (HP:0001659) | 2.46845881 |
52 | Subaortic stenosis (HP:0001682) | 2.46521113 |
53 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.46521113 |
54 | Asymmetric septal hypertrophy (HP:0001670) | 2.45973786 |
55 | Acanthosis nigricans (HP:0000956) | 2.45470621 |
56 | Aneurysm (HP:0002617) | 2.43840524 |
57 | Joint stiffness (HP:0001387) | 2.43129796 |
58 | Pulmonary artery stenosis (HP:0004415) | 2.41934345 |
59 | * Mitral valve prolapse (HP:0001634) | 2.40241143 |
60 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.39752394 |
61 | Facial diplegia (HP:0001349) | 2.39474626 |
62 | Muscle fiber inclusion bodies (HP:0100299) | 2.37080765 |
63 | Rhabdomyolysis (HP:0003201) | 2.33407017 |
64 | Generalized amyotrophy (HP:0003700) | 2.33331103 |
65 | Limb-girdle muscle weakness (HP:0003325) | 2.31499291 |
66 | Neoplasm of the heart (HP:0100544) | 2.31053471 |
67 | Systemic lupus erythematosus (HP:0002725) | 2.29897851 |
68 | Bundle branch block (HP:0011710) | 2.29197298 |
69 | * Wormian bones (HP:0002645) | 2.27005446 |
70 | * Soft skin (HP:0000977) | 2.24096290 |
71 | Limited hip movement (HP:0008800) | 2.23962873 |
72 | Distal arthrogryposis (HP:0005684) | 2.21186342 |
73 | Alopecia of scalp (HP:0002293) | 2.20997271 |
74 | Aortic valve stenosis (HP:0001650) | 2.17939139 |
75 | Syncope (HP:0001279) | 2.17507934 |
76 | Peritonitis (HP:0002586) | 2.16876084 |
77 | Prolonged QT interval (HP:0001657) | 2.14900964 |
78 | Ventricular arrhythmia (HP:0004308) | 2.11185445 |
79 | Mitral regurgitation (HP:0001653) | 2.10611566 |
80 | Oligomenorrhea (HP:0000876) | 2.09228112 |
81 | Neck muscle weakness (HP:0000467) | 2.09153471 |
82 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.08014686 |
83 | Osteolytic defects of the hand bones (HP:0009699) | 2.08014686 |
84 | Testicular atrophy (HP:0000029) | 2.07857068 |
85 | Palpitations (HP:0001962) | 2.07481766 |
86 | * Dilatation of the ascending aorta (HP:0005111) | 2.06029955 |
87 | Ectopia lentis (HP:0001083) | 2.05149351 |
88 | Flat cornea (HP:0007720) | 2.04221924 |
89 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02762825 |
90 | Lower limb amyotrophy (HP:0007210) | 2.02303124 |
91 | Bronchomalacia (HP:0002780) | 2.01341144 |
92 | Lymphangioma (HP:0100764) | 2.00464938 |
93 | Neonatal short-limb short stature (HP:0008921) | 1.98492485 |
94 | Overgrowth (HP:0001548) | 1.98399376 |
95 | Scapular winging (HP:0003691) | 1.97596679 |
96 | Atrioventricular block (HP:0001678) | 1.97287882 |
97 | * Joint laxity (HP:0001388) | 1.96797272 |
98 | Complement deficiency (HP:0004431) | 1.96062835 |
99 | Abnormal atrioventricular conduction (HP:0005150) | 1.96043000 |
100 | Hypoplasia of the iris (HP:0007676) | 1.95971087 |
101 | Vertebral compression fractures (HP:0002953) | 1.95658026 |
102 | Conjunctival hamartoma (HP:0100780) | 1.95132266 |
103 | Distal lower limb muscle weakness (HP:0009053) | 1.94426900 |
104 | Muscle stiffness (HP:0003552) | 1.92303679 |
105 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91761995 |
106 | Muscular dystrophy (HP:0003560) | 1.87856349 |
107 | Persistence of primary teeth (HP:0006335) | 1.87575456 |
108 | Hypoventilation (HP:0002791) | 1.87305076 |
109 | Nemaline bodies (HP:0003798) | 1.87252213 |
110 | Heart block (HP:0012722) | 1.87037735 |
111 | Thin bony cortex (HP:0002753) | 1.85381771 |
112 | Abnormality of the 4th metacarpal (HP:0010012) | 1.84846246 |
113 | Mitral stenosis (HP:0001718) | 1.84263594 |
114 | Emphysema (HP:0002097) | 1.84048743 |
115 | Wide anterior fontanel (HP:0000260) | 1.83603975 |
116 | Hypertriglyceridemia (HP:0002155) | 1.83555324 |
117 | Elbow flexion contracture (HP:0002987) | 1.83327082 |
118 | Hip contracture (HP:0003273) | 1.80941429 |
119 | Bulbar palsy (HP:0001283) | 1.80492617 |
120 | Distal lower limb amyotrophy (HP:0008944) | 1.80308286 |
121 | Bradycardia (HP:0001662) | 1.80182183 |
122 | Hypoplastic ischia (HP:0003175) | 1.79761128 |
123 | Achilles tendon contracture (HP:0001771) | 1.79653356 |
124 | Foot dorsiflexor weakness (HP:0009027) | 1.79468514 |
125 | Blue sclerae (HP:0000592) | 1.78322155 |
126 | Genu recurvatum (HP:0002816) | 1.77465677 |
127 | Skin nodule (HP:0200036) | 1.77461123 |
128 | Broad face (HP:0000283) | 1.75160689 |
129 | Milia (HP:0001056) | 1.74955398 |
130 | Mesangial abnormality (HP:0001966) | 1.74856376 |
131 | Hypoalphalipoproteinemia (HP:0003233) | 1.74069309 |
132 | Hypoglycemic coma (HP:0001325) | 1.73955745 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TTN | 4.99459319 |
2 | TRIB3 | 4.40265162 |
3 | OBSCN | 3.03943600 |
4 | SIK1 | 2.99187496 |
5 | LMTK2 | 2.79905537 |
6 | MYLK | 2.78625864 |
7 | RIPK1 | 2.70879164 |
8 | CAMK1D | 2.59883128 |
9 | DMPK | 2.43732829 |
10 | TIE1 | 2.41258003 |
11 | PHKG1 | 2.34882514 |
12 | PHKG2 | 2.34882514 |
13 | PKN2 | 2.19022210 |
14 | ERN1 | 2.10062097 |
15 | BCKDK | 2.08764803 |
16 | PDK3 | 2.08293793 |
17 | PDK4 | 2.08293793 |
18 | PDGFRA | 2.07645859 |
19 | CAMK1G | 1.98999879 |
20 | TGFBR2 | 1.95986316 |
21 | DDR2 | 1.62218529 |
22 | PIK3CA | 1.61473173 |
23 | LATS1 | 1.61123515 |
24 | MST1R | 1.58754507 |
25 | PRPF4B | 1.46982410 |
26 | FGFR4 | 1.44096326 |
27 | EPHB1 | 1.43862658 |
28 | FER | 1.40026570 |
29 | PDK2 | 1.37009508 |
30 | MAPK7 | 1.32467875 |
31 | EPHB2 | 1.25284133 |
32 | INSRR | 1.17233656 |
33 | AKT3 | 1.13981419 |
34 | MAPKAPK3 | 1.13171101 |
35 | PRKAA2 | 1.10176829 |
36 | FGFR2 | 1.09439309 |
37 | MAP3K7 | 1.09347731 |
38 | PRKD1 | 1.05413045 |
39 | KIT | 1.02537567 |
40 | PTK6 | 1.01477258 |
41 | FGFR3 | 0.98229656 |
42 | EPHA3 | 0.96011326 |
43 | MAP3K3 | 0.95292052 |
44 | MAPK4 | 0.94001442 |
45 | MAP2K3 | 0.93624278 |
46 | ILK | 0.92724066 |
47 | MET | 0.86844881 |
48 | TESK1 | 0.86806133 |
49 | PIK3CG | 0.84633257 |
50 | ROCK1 | 0.82482482 |
51 | PDGFRB | 0.81026810 |
52 | JAK1 | 0.80786043 |
53 | PRKCH | 0.78681380 |
54 | PTK2B | 0.78591411 |
55 | HIPK2 | 0.77668692 |
56 | SGK2 | 0.77559063 |
57 | PAK2 | 0.76808395 |
58 | SGK3 | 0.76027390 |
59 | SGK223 | 0.73390178 |
60 | SGK494 | 0.73390178 |
61 | NLK | 0.72636967 |
62 | EEF2K | 0.72491635 |
63 | PRKAA1 | 0.71455305 |
64 | TRPM7 | 0.71062560 |
65 | MTOR | 0.70736130 |
66 | LATS2 | 0.70450878 |
67 | PINK1 | 0.70360705 |
68 | MAPK12 | 0.68433688 |
69 | GRK5 | 0.67217432 |
70 | NTRK1 | 0.66565569 |
71 | RET | 0.63883991 |
72 | ICK | 0.60449932 |
73 | PAK3 | 0.59971860 |
74 | ABL2 | 0.55580649 |
75 | FRK | 0.55479304 |
76 | FGFR1 | 0.55055002 |
77 | BMX | 0.54970517 |
78 | MAPK15 | 0.54665418 |
79 | MAP2K1 | 0.53992598 |
80 | CDC42BPA | 0.53206471 |
81 | KDR | 0.53041357 |
82 | NEK9 | 0.52313455 |
83 | MAP3K1 | 0.52104527 |
84 | ROCK2 | 0.50984455 |
85 | CSK | 0.50916024 |
86 | MAP3K6 | 0.50745448 |
87 | MUSK | 0.50178243 |
88 | LRRK2 | 0.49443874 |
89 | MAPKAPK5 | 0.49379486 |
90 | ADRBK1 | 0.49251702 |
91 | PDPK1 | 0.47579247 |
92 | PRKD3 | 0.47388467 |
93 | CAMK2G | 0.46677041 |
94 | PTK2 | 0.45996153 |
95 | GSK3A | 0.45891841 |
96 | JAK2 | 0.45436741 |
97 | DAPK3 | 0.45194101 |
98 | BLK | 0.43755616 |
99 | NEK1 | 0.43559358 |
100 | STK38 | 0.42068465 |
101 | MARK2 | 0.41497515 |
102 | PRKD2 | 0.41397988 |
103 | MAP3K10 | 0.41370501 |
104 | MARK1 | 0.41311396 |
105 | FLT3 | 0.41245551 |
106 | STK24 | 0.41233910 |
107 | MAPK3 | 0.41211832 |
108 | CAMK2D | 0.39792983 |
109 | EPHA2 | 0.38878899 |
110 | MAPK1 | 0.38638035 |
111 | PAK4 | 0.38463985 |
112 | PRKG1 | 0.37990902 |
113 | RPS6KA2 | 0.37220890 |
114 | ZAP70 | 0.36732994 |
115 | PRKACG | 0.36660008 |
116 | PRKG2 | 0.36512502 |
117 | CAMK4 | 0.36390938 |
118 | RPS6KC1 | 0.36153125 |
119 | RPS6KL1 | 0.36153125 |
120 | WNK1 | 0.35744654 |
121 | RPS6KA6 | 0.31419407 |
122 | CAMK1 | 0.30956002 |
123 | PKN1 | 0.30725643 |
124 | STK3 | 0.28890753 |
125 | MAPK11 | 0.28586272 |
126 | TAOK1 | 0.28418310 |
127 | DAPK2 | 0.25839274 |
128 | SRC | 0.25810440 |
129 | PDK1 | 0.24385971 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.63197281 |
2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.02825760 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.83651970 |
4 | * ECM-receptor interaction_Homo sapiens_hsa04512 | 2.83376389 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63972653 |
6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.57303086 |
7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.55122607 |
8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.52941673 |
9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.44988413 |
10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.41967799 |
11 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.33392142 |
12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.32775548 |
13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26598858 |
14 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.02857866 |
15 | * Focal adhesion_Homo sapiens_hsa04510 | 1.85715944 |
16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.73043005 |
17 | Insulin resistance_Homo sapiens_hsa04931 | 1.58316619 |
18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47889314 |
19 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.47651011 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46029411 |
21 | Amoebiasis_Homo sapiens_hsa05146 | 1.42191372 |
22 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40503663 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.39790226 |
24 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.31071494 |
25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.29160759 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.23536403 |
27 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.22084803 |
28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19935473 |
29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16606975 |
30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15860893 |
31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.13182963 |
32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11513708 |
33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02375211 |
34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01516510 |
35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00454690 |
36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00380739 |
37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.98183651 |
38 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97153746 |
39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.94442333 |
40 | Histidine metabolism_Homo sapiens_hsa00340 | 0.92059277 |
41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91069882 |
42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.90447091 |
43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89382976 |
44 | Gap junction_Homo sapiens_hsa04540 | 0.89013075 |
45 | Lysine degradation_Homo sapiens_hsa00310 | 0.88297615 |
46 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.87590520 |
47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.86588429 |
48 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85475678 |
49 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85322567 |
50 | Renin secretion_Homo sapiens_hsa04924 | 0.84191068 |
51 | Adherens junction_Homo sapiens_hsa04520 | 0.83744621 |
52 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83271380 |
53 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82782271 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82198024 |
55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81097241 |
56 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76602214 |
57 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76356422 |
58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.75449044 |
59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.73321273 |
60 | Pertussis_Homo sapiens_hsa05133 | 0.73003902 |
61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72617689 |
62 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71661520 |
63 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.69133467 |
64 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.66884827 |
65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65680111 |
66 | Platelet activation_Homo sapiens_hsa04611 | 0.65668879 |
67 | Glioma_Homo sapiens_hsa05214 | 0.65347378 |
68 | Malaria_Homo sapiens_hsa05144 | 0.65281691 |
69 | Axon guidance_Homo sapiens_hsa04360 | 0.64926237 |
70 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.62853253 |
71 | ABC transporters_Homo sapiens_hsa02010 | 0.62581498 |
72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.62434248 |
73 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62294339 |
74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62038674 |
75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61748593 |
76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.61111760 |
77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61042650 |
78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61014110 |
79 | Tight junction_Homo sapiens_hsa04530 | 0.58354659 |
80 | Bile secretion_Homo sapiens_hsa04976 | 0.57936811 |
81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.57273594 |
82 | Peroxisome_Homo sapiens_hsa04146 | 0.57138448 |
83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.56504019 |
84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55083281 |
85 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54599000 |
86 | Insulin secretion_Homo sapiens_hsa04911 | 0.54523834 |
87 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54402186 |
88 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52105100 |
89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.52076056 |
90 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51150405 |
91 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50349600 |
92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48931633 |
93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.47800591 |
94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47636941 |
95 | Melanoma_Homo sapiens_hsa05218 | 0.47486970 |
96 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.47281684 |
97 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47023649 |
98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.46412348 |
99 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45743279 |
100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.45306892 |
101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.44507061 |
102 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.43916839 |
103 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43509498 |
104 | Prion diseases_Homo sapiens_hsa05020 | 0.42928516 |
105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42690788 |
106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41874603 |
107 | * MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.41653574 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.41318003 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.38511900 |
110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37267598 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36935532 |
112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36417943 |
113 | Pathways in cancer_Homo sapiens_hsa05200 | 0.35904028 |
114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.35871348 |
115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33907208 |
116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32676041 |
117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.30596094 |
118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.30263113 |
119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28736758 |
120 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.27791782 |
121 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27697664 |
122 | Melanogenesis_Homo sapiens_hsa04916 | 0.25592015 |
123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25531200 |
124 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25228240 |
125 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.25113654 |
126 | Salivary secretion_Homo sapiens_hsa04970 | 0.23755043 |
127 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23297789 |
128 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.22954116 |